Two cool things stood out to me: unsolicited BP partnerships mentioned by SK + NP; and the fact that CR has a fully-staffed lab. I still think NP needs to step down or at least step back but I didn't hate this call.

Quote:

---

That call seemed up beat and positive. I'm glad to hear that we have a time for HIV and that the cancer trials are enrolling.

Don't understand the comment about the Phillipines being on the back burner.

It seems like Long Haulers is our primary catalyst now.

The p values they were citing were amazing. But, the actual data is beyond me. I understand the scale, but not the method for obtaining those p values.

Was he suggesting that if we measured the patients daily the p value would be .0001?

Read More: https://investorshangout.com/post/view?id=616...z6ySunBef2

---